Clover Health Investments Price to Sales Ratio 2020-2024 | CLOV
Historical PS ratio values for Clover Health Investments (CLOV) over the last 10 years. The current P/S ratio for Clover Health Investments as of December 02, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Clover Health Investments P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-11-29 | 3.48 | 0.82 | |
| 2024-09-30 | 2.82 | $4.26 | 0.66 |
| 2024-06-30 | 1.23 | $4.22 | 0.29 |
| 2024-03-31 | 0.79 | $4.17 | 0.19 |
| 2023-12-31 | 0.95 | $4.12 | 0.23 |
| 2023-09-30 | 1.08 | $3.76 | 0.29 |
| 2023-06-30 | 0.90 | $4.92 | 0.18 |
| 2023-03-31 | 0.85 | $6.03 | 0.14 |
| 2022-12-31 | 0.93 | $6.51 | 0.14 |
| 2022-09-30 | 1.70 | $5.65 | 0.30 |
| 2022-06-30 | 2.14 | $4.87 | 0.44 |
| 2021-12-31 | 3.72 | $3.62 | 1.03 |
| 2021-09-30 | 7.39 | $4.45 | 1.66 |
| 2021-06-30 | 13.32 | $5.27 | 2.53 |
| 2021-03-31 | 7.56 | $4.94 | 1.53 |
| 2020-12-31 | 16.77 | $5.11 | 3.28 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.744B | $2.034B |
| Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $9.855B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.039B | 179.00 |
| Inspire Medical Systems (INSP) | United States | $5.776B | 180.15 |
| Enovis (ENOV) | United States | $2.727B | 18.49 |
| IRhythm Technologies (IRTC) | United States | $2.722B | 0.00 |
| Privia Health (PRVA) | United States | $2.578B | 214.80 |
| Omnicell (OMCL) | United States | $2.158B | 70.59 |
| Azenta (AZTA) | United States | $2.106B | 112.71 |
| 10x Genomics (TXG) | United States | $1.925B | 0.00 |
| Schrodinger (SDGR) | United States | $1.644B | 0.00 |
| Phreesia (PHR) | United States | $1.215B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.701B | 0.00 |
| Standard BioTools (LAB) | United States | $0.685B | 0.00 |
| Talkspace (TALK) | United States | $0.578B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.560B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.546B | 94.60 |
| Health Catalyst (HCAT) | United States | $0.537B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 78.04 |
| Pulmonx (LUNG) | United States | $0.255B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.223B | 0.00 |
| American Well (AMWL) | United States | $0.147B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.109B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.090B | 0.00 |
| HeartBeam (BEAT) | United States | $0.082B | 0.00 |
| 111 (YI) | China | $0.071B | 0.00 |
| CareCloud (CCLD) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | China | $0.047B | 0.00 |
| Outset Medical (OM) | United States | $0.047B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Movano (MOVE) | United States | $0.037B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.011B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |